Schölkens B[au] - Search Results

Year	Number of Results
1966	1
1968	1
1969	1
1970	1
1971	1
1974	5
1975	3
1977	3
1978	2
1979	4
1980	5
1981	3
1982	4
1983	4
1984	10
1985	3
1986	3
1987	6
1988	10
1989	8
1990	3
1991	6
1992	13
1993	9
1994	12
1995	7
1996	11
1997	10
1998	8
1999	6
2000	4
2001	4
2002	1
2007	1
2022	0

1

ACE inhibition and atherogenesis.

Schölkens BA, Landgraf W. Schölkens BA, et al. Can J Physiol Pharmacol. 2002 Apr;80(4):354-9. doi: 10.1139/y02-038. Can J Physiol Pharmacol. 2002. PMID: 12025972 Review.

2

Biological activities of 6-keto-prostaglandin E1.

Lewis R, Schölkens BA, Beck G. Lewis R, et al. Among authors: scholkens ba. Prostaglandins Leukot Med. 1984 Dec;16(3):303-24. doi: 10.1016/0262-1746(84)90188-4. Prostaglandins Leukot Med. 1984. PMID: 6098901 Review.

3

Kinins in the cardiovascular system.

Schölkens BA. Schölkens BA. Immunopharmacology. 1996 Jun;33(1-3):209-16. doi: 10.1016/0162-3109(96)00061-6. Immunopharmacology. 1996. PMID: 8856152 Review.

4

Kinin receptor antagonists: unique probes in basic and clinical research.

Wirth KJ, Heitsch H, Schölkens BA. Wirth KJ, et al. Among authors: scholkens ba. Can J Physiol Pharmacol. 1995 Jul;73(7):797-804. doi: 10.1139/y95-108. Can J Physiol Pharmacol. 1995. PMID: 8846412 Review.

5

Interactions among ACE, kinins and NO.

Linz W, Wohlfart P, Schölkens BA, Malinski T, Wiemer G. Linz W, et al. Among authors: scholkens ba. Cardiovasc Res. 1999 Aug 15;43(3):549-61. doi: 10.1016/s0008-6363(99)00091-7. Cardiovasc Res. 1999. PMID: 10690327 Review. No abstract available.

6

Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.

Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA. Linz W, et al. Among authors: scholkens ba. Pharmacol Rev. 1995 Mar;47(1):25-49. Pharmacol Rev. 1995. PMID: 7784479 Review.

7

Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.

Linz W, Schölkens BA. Linz W, et al. Among authors: scholkens ba. J Cardiovasc Pharmacol. 1992;20 Suppl 9:S83-90. J Cardiovasc Pharmacol. 1992. PMID: 1282635 Review.

8

Antihypertensive and cardioprotective effects after angiotensin-converting enzyme inhibition: role of kinins.

Tschöpe C, Gohlke P, Zhu YZ, Linz W, Schölkens B, Unger T. Tschöpe C, et al. Among authors: scholkens b. J Card Fail. 1997 Jun;3(2):133-48. doi: 10.1016/s1071-9164(97)90047-6. J Card Fail. 1997. PMID: 9220313 Review.

9

Beneficial effects of bradykinin on myocardial energy metabolism and infarct size.

Linz W, Wiemer G, Schölkens BA. Linz W, et al. Among authors: scholkens ba. Am J Cardiol. 1997 Aug 4;80(3A):118A-123A. doi: 10.1016/s0002-9149(97)00466-9. Am J Cardiol. 1997. PMID: 9293964 Review.

10

Ramipril: review of pharmacology.

Becker RA, Schölkens B. Becker RA, et al. Among authors: scholkens b. Am J Cardiol. 1987 Apr 24;59(10):3D-11D. doi: 10.1016/0002-9149(87)90045-2. Am J Cardiol. 1987. PMID: 3034030

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results